Well, I'd like to hear from you to tell me how good.
I've spent the past few weeks reflecting on my own trading transformation in 2025—the wins, the lessons, the shifts in confidence and approach. But I'm...
We've been talking about this for a long time: this year is NOT last year.
The things that worked for the last 3 quarters of 2020 are not working in 2021. Stocks are a mess. Growth is a massive underperformer. Small-caps can't stop churning...
Key Takeaway: Stocks looking at a year two market. Stocks looking at a year of two markets. Economic surprises remain a tailwind for now but data struggling to keep up with...
The latest Young Aristocrats report dropped on Friday last week. If you love dividends combined with momentum (who wouldn't?), then this report is always a must...
Our Top 10 report was just published. In this weekly note, we highlight 10 of the most important charts or themes we're currently seeing in asset classes around the world.
So commodities seem like they're in the mood to rally! We've seen Base Metals have their fair share of moments in the spotlight, but what about the truly shiny commodities? Where are Gold and Silver off to, next? Or are they consolidating and quietly...
This week we're looking at two long setups in the Pharma sector. With Nifty Pharma breaking out above its resistance of 13,500, a couple of stocks that we've been tracking for quite some time now have also followed through with a breakout.
We retired our "Five Bull Market Barometers" in mid-July to make room for a new weekly post that's focused on the three most important charts for the week ahead.
Dividend aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily increasing...